HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Salicylic Acid Antimicrobial Efficacy, Persistence Illustrated By In Vivo Tests

This article was originally published in The Rose Sheet

Executive Summary

The efficacy of salicylic acid as an antimicrobial ingredient has been established against a "broad spectrum of microorganisms" including bacteria, yeast and mold, Procter & Gamble told FDA in a citizen petition submitted Sept. 5.

You may also be interested in...



Salicylic Acid Historical Safety Supports Antibacterial Approval - P&G

Salicylic acid's history of safe and effective use in skin treatment and anti-dandruff products is sufficient grounds for classifying the ingredient as a Category I antibacterial active, according to Procter & Gamble.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

UsernamePublicRestriction

Register

LL1132972

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel